Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand

Molecular and Cellular Endocrinology

Volumn 347, Issue 1-2, 2011, Pages 3-10

  Pike, J Wesley ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Acetylation; ChIP seq; CYP24A1; Enhancers; Tnfsf11 Rankl; VDR

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE;

ALOX5 GENE; CELL GROWTH; CELLULAR DISTRIBUTION; CYP24A1 GENE; DIMERIZATION; ENHANCER REGION; GENE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE TARGETING; GENETIC ASSOCIATION; HORMONE ACTION; HUMAN; INTESTINE CELL; LIGAND BINDING; MARKER GENE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RANKL GENE; REVIEW; RXR GENE; TNFS11 GENE; VDR GENE; VIRUS CELL INTERACTION;

B-LYMPHOCYTES; CALCITRIOL; COLON; GENE EXPRESSION REGULATION; GENOME, HUMAN; HERPESVIRUS 4, HUMAN; HUMANS; INTESTINES; LIGANDS; OSTEOBLASTS; PARATHYROID HORMONE; RANK LIGAND; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES;

EID: 81255134189     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.05.012     Document Type: Review

References (73)

1. Aguilera O., Peña C., García J.M., Larriba M.J., Ordóñez-Morán P., Navarro D., Barbáchano A., López de Silanes I., Ballestar E., Fraga M.F., et al. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha, 25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 2007, 28:1877-1884.
2. Bernstein B.E., Stamatoyannopoulos J.A., Costello J.F., Ren B., Milosavljevic A., Meissner A., Kellis M., Marra M.A., Beaudet A.L., Ecker J.R., et al. The NIH roadmap epigenomics mapping consortium. Nat. Biotechnol. 2010, 28:1045-1048.
3. Bishop K.A., Meyer M.B., Pike J.W. A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression. Mol. Endocrinol. 2009, 23:2095-2110.
4. Bouillon R., Bischoff-Ferrari H., Willett W. Vitamin D and health: perspectives from mice and man. J. Bone Miner. Res. 2008, 23:974-979.
5. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., Lieben L., Mathieu C., Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29:726-776.
6. Bouillon R., Eelen G., Verlinden L., Mathieu C., Carmeliet G., Verstuyf A. Vitamin D and cancer. J. Steroid Biochem. Mol. Biol. 2006, 102:156-162.
7. Burgess T., Qian Y., Kaufman S., Ring B., Van G., Capparelli C., Kelley M., Hsu H., Boyle W., Dunstan C., et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 1999, 145:527-538.
8. Dekker J., Rippe K., Dekker M., Kleckner N. Capturing chromosome conformation. Science 2002, 295:1306-1311.
9. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80:1689S-1696S.
10. Ernst J., Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 2010, 28:817-825.
11. Fu Q., Manolagas S.C., O'Brien C.A. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol. Cell. Biol. 2006, 26:6453-6468.
12. Galli C., Zella L.A., Fretz J.A., Fu Q., Pike J.W., Weinstein R.S., Manolagas S.C., O'Brien C.A. Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass. Endocrinology 2008, 149:146-153.
13. Haussler M.R., Haussler C.A., Bartik L., Whitfield G.K., Hsieh J.C., Slater S., Jurutka P.W. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr. Rev. 2008, 66:S98-112.
14. Haussler M.R., Haussler C.A., Whitfield G.K., Hsieh J.C., Thompson P.D., Barthel T.K., Bartik L., Egan J.B., Wu Y., Kubicek J.L., et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J. Steroid Biochem. Mol. Biol. 2010, 121:88-97.
15. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 1998, 13:325-349.
16. Hawkins R.D., Hon G.C., Lee L.K., Ngo Q., Lister R., Pelizzola M., Edsall L.E., Kuan S., Luu Y., Klugman S., et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 2010, 6:479-491.
17. Hawkins R.D., Hon G.C., Ren B. Next-generation genomics: an integrative approach. Nat. Rev. Genet. 2010, 8:476-486.
18. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., Ye Z., Lee L.K., Stuart R.K., Ching C.W., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
19. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
20. Heinz S., Benner C., Spann N., Bertolino E., Lin Y., Laslo P., Cheng J., Murre C., Singh H., Glass C. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
21. Hon G.C., Hawkins R.D., Ren B. Predictive chromatin signatures in the mammalian genome. Hum. Mol. Genet. 2009, 18:R195-201.
22. Kato S., Fujiki R., Kim M.S., Kitagawa H. Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC. J. Steroid Biochem. Mol. Biol. 2007, 103:372-380.
23. Kerner S.A., Scott R.A., Pike J.W. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc. Natl Acad. Sci. USA 1989, 86:4455-4459.
24. Kim M., Kondo T., Takada I., Youn M., Yamamoto Y., Takahashi S., Matsumoto T., Fujiyama S., Shirode Y., Yamaoka I., et al. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009, 461:1007-1012.
25. Kim S., Shevde N.K., Pike J.W. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res. 2005, 20:305-317.
26. Kim S., Yamazaki M., Shevde N.K., Pike J.W. Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol. Endocrinol. 2007, 21:197-214.
27. Kim S., Yamazaki M., Zella L.A., Shevde N.K., Pike J.W. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol. Cell. Biol. 2006, 26:6469-6486.
28. Kirmizis A., Bartley S.M., Kuzmichev A., Margueron R., Reinberg D., Green R., Farnham P.J. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 2004, 18:1592-1605.
29. 3. J. Cell. Biochem. 2008, 105:1289-1297.
30. 3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J. Cell. Biochem. 2003, 89:771-777.
31. Komashko V.M., Acevedo L.G., Squazzo S.L., Iyengar S.S., Rabinovich A., O'Geen H., Green R., Farnham P.J. Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells. Genome Res. 2008, 18:521-532.
32. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
33. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
34. Lefterova M., Zhang Y., Steger D., Schupp M., Schug J., Cristancho A., Feng D., Zhuo D., Stoeckert C.J., Liu X., et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008, 22:2941-2952.
35. Leibbrandt A., Penninger J.M. RANK/RANKL: regulators of immune responses and bone physiology. Ann. NY Acad. Sci. 2008, 1143:123-150.
36. Lin Y.C., Jhunjhunwala S., Benner C., Heinz S., Welinder E., Mansson R., Sigvardsson M., Hagman J., Espinoza C.A., Dutkowski J., et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat. Immunol. 2010, 11:635-643.
37. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell 1995, 83:841-850.
38. Matthews D., LaPorta E., Zinser G.M., Narvaez C.J., Welsh J. Genomic vitamin D signaling in breast cancer: insights from animal models and human cells. J. Steroid Biochem. Mol. Biol. 2010, 121:362-367.
39. Meyer, M.B., Goetsch, P., and Pike, J., submitted for publication. Overlapping VDR/RXR and TCF4/b-catenin cistromes in colorectal cancer cells: impact on c-FOS and c-MYC regulation.
40. Meyer M., Goetsch P., Pike J. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J. Steroid Biochem. Mol. Biol. 2010, 121:136-141.
41. Meyer M.B., Goetsch P.D., Pike J.W. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha, 25-dihydroxyvitamin D3. J. Biol. Chem. 2010, 285:15599-15610.
42. Meyer M.B., Zella L.A., Nerenz R.D., Pike J.W. Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo. J. Biol. Chem. 2007, 282:22344-22352.
43. Nerenz R.D., Martowicz M.L., Pike J.W. An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 2008, 22:1044-1056.
44. O'Brien C.A. Control of RANKL gene expression. Bone 2010, 46:911-919.
45. 3 24-hydroxylase. Biochemistry 1993, 32:76-82.
46. Ohyama Y., Noshiro M., Okuda K. Cloning and expression of cDNA encoding 25-hydroxyvitamin D3 24-hydroxylase. FEBS Lett. 1991, 278:195-198.
47. 3 24-hydroxylase gene. J. Biol. Chem. 1996, 271:30381-30385.
48. Ong C.T., Corces V.G. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 2011, 12:283-293.
49. Ozono K., Liao J., Kerner S.A., Scott R.A., Pike J.W. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J. Biol. Chem. 1990, 265:21881-21888.
50. Pike J.W. Genome-scale technique highlight the epigenome and redefine fundamental principles of gene regulation. J. Bone Miner. Res. 2011.
51. Pike J.W., Meyer M.B. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Endocrinol. Metabol. Clin. North Am. 2010, 39:255-269. (table of contents).
52. Pike J.W., Meyer M.B., Martowicz M.L., Bishop K.A., Lee S.M., Nerenz R.D., Goetsch P.D. Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 2010, 121:130-135.
53. Plum L.A., DeLuca H.F. Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discovery 2010, 9:941-955.
54. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 2004, 29:664-673.
55. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., Erdjument-Bromage H., Tempst P., Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999, 398:824-828.
56. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., Handunnetthi L., Handel A.E., Disanto G., Orton S.M., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010, 20:1352-1360.
57. Seuter S., Väisänen S., Rådmark O., Carlberg C., Steinhilber D. Functional characterization of vitamin D responding regions in the human 5-lipoxygenase gene. Biochim. Biophys. Acta 2007, 1771:864-872.
58. Smith C.L., O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 2004, 25:45-71.
59. Sone T., Kerner S., Pike J.W. Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer. J. Biol. Chem. 1991, 266:23296-23305.
60. Sone T., Ozono K., Pike J.W. A 55-kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol. Endocrinol. 1991, 5:1578-1586.
61. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation. Endocr. Rev. 1992, 13:66-80.
62. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M., Martin T. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 1999, 20:345-357.
63. Suh E., Traber P. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol. Cell. Biol. 1996, 16:619-625.
64. Sutton A.L., MacDonald P.N. Vitamin D: more than a "bone-a-fide" hormone. Mol. Endocrinol. 2003, 17:777-791.
65. Szutorisz H., Dillon N., Tora L. The role of enhancers as centres for general transcription factor recruitment. Trends Biochem. Sci. 2005, 30:593-599.
66. Theill L.E., Boyle W.J., Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 2002, 20:795-823.
67. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454:126-130.
68. Wells J., Farnham P.J. Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 2002, 26:48-56.
69. Yuan C., Ito M., Fondell J., Fu Z., Roeder R. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl Acad. Sci. USA 1998, 95:7939-7944.
70. Zella L., Meyer M., Nerenz R., Lee S., Martowicz M., Pike J. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 2010, 24:128-147.
71. Zella L.A., Kim S., Shevde N.K., Pike J.W. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 2006, 20:1231-1247.
72. Zierold C., Darwish H.M., DeLuca H.F. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J. Biol. Chem. 1995, 270:1675-1678.
73. 3 receptor ablation on murine mammary gland development and tumorigenesis. J. Steroid Biochem. Mol. Biol. 2004, 89-90:433-436.